Kala Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors

Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases

Sesen Bio Announces Proposed Public Offering of Common Stock and Warrants

Sage Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference